Cited by 163Ubiquitin and proteasome pathwaysCancer-related Molecular PathwaysProtein Degradation and Inhibitors

The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.

Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases.

Open access

Bhattacharya, Seemana, Chakraborty, Dipankar, Basu, Malini, Ghosh, Mrinal K·2018·Signal Transduction and Targeted Therapy

DOI 10.1038/s41392-018-0012-yPMC PMC6023882

Open this paper in CoChat — free account Open PDF

Abstract

Herpesvirus-associated ubiquitin-specific protease (HAUSP) is a USP family deubiquitinase. HAUSP is a protein of immense biological importance as it is involved in several cellular processes, including host-virus interactions, oncogenesis and tumor suppression, DNA damage and repair processes, DNA dynamics and epigenetic modulations, regulation of gene expression and protein function, spatio-temporal distribution, and immune functions. Since its discovery in the late 1990s as a protein interacting with a herpes virus regulatory protein, extensive studies have assessed its complex roles in p53-MDM2-related networks, identified numerous additional interacting partners, and elucidated the different roles of HAUSP in the context of cancer, development, and metabolic and neurological pathologies. Recent analyses have provided new insights into its biochemical and functional dynamics. In this review, we provide a comprehensive account of our current knowledge about emerging insights into HAUSP in physiology and diseases, which shed light on fundamental biological questions and promise to provide a potential target for therapeutic intervention.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41392-018-0012-y

Cites

114 of 114 references verified0 citation errors · 0 not checkable

Statistics

Fig. 1 Mode of action of ubiquitin ligases and deubiquitinases for maintenance of the cellular protein pool. Pictorial representation of the 26s proteasomal degradation pathway where a series of ubiquitin ligases (E1, E2, E3) sequentially polyubiqutinate proteins for degradation. Deubiqutinases (DUBs) remove ubiquitin from proteins for their activation or escape from degradation. Altogether, these pathways maintain cellular homeostasis by regulating cellular protein poolCC BY · PubMed Central

Fig. 2 The HAUSP timeline: 20 years of research. A schematic representation of the 20 years of research on HAUSP from its discovery to the current findings and the relevant discoveries in different phasesCC BY · PubMed Central

Fig. 3 Domain structure of HAUSP. a Pictorial representation of HAUSP demonstrating the different domains and binding sites for major interacting partners. b Predictive representation of the complete HAUSP structure (by superimposing pdb structures 4yoc, 5fwi, and 2f1z) with domains representing their respective binding partners ICP0, p53, and EBNA1CC BY · PubMed Central

Fig. 4 Role of USP7/HAUSP in multiple cellular events. Figure depicts involvement of USP7/HAUSP in multiple cellular events (a Viral-protein association; b DNA damage response; c Epigenetic functions; d Hypoxia; e Immune functions; and f Endosomal functions)CC BY · PubMed Central

Fig. 5 Major interacting partners/substrates of USP7/HAUSP. Figure presents various crucial interacting oncoproteins and tumor suppressors of USP7/HAUSP with various post-translational modifications (phosphorylation, ubiquitination, deubiquitination, etc.)CC BY · PubMed Central

Fig. 6 Regulation of HAUSP. A pictorial representation of the different modes of HAUSP regulation (a Transcriptional and b Post-translational)CC BY · PubMed Central

Fig. 7 Structures and IC50 values of potential HAUSP inhibitors. A diagrammatic representation of the chemical structures of potential inhibitors of HAUSP with their reported IC50 valuesCC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Mechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184
Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.
Reyes-Turcu, F. E., Ventii, K. H., & Wilkinson, K. D. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082307.091526 · Cited by 1,396
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., & Gu, W. J. (2002) · Nature · doi:10.1038/nature737 · Cited by 1,048
Mechanism and function of deubiquitinating enzymes
Amerik, A. Y., & Hochstrasser, M. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.10.003 · Cited by 1,010
A dynamic role of HAUSP in the p53-Mdm2 pathway
Li, M., Brooks, C. L., Kon, N., & Gu, W. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00157-1 · Cited by 679
Crystal Structure of a UBP-Family Deubiquitinating Enzyme in Isolation and in Complex with Ubiquitin Aldehyde
Hu, M., Li, P., Li, M., Li, W., Yao, T., Wu, J.-W., Gu, W. J., Cohen, R. E., & Shi, Y. (2002) · Cell · doi:10.1016/s0092-8674(02)01199-6 · Cited by 666
Atypical ubiquitylation — the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages
Kulathu, Y., & Komander, D. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3394 · Cited by 619
A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance.
Chauhan, D., Tian, Z., Nicholson, B., Kumar, K. G. S., Zhou, B., Carrasco, R., McDermott, J. L., Leach, C. A., Fulcinniti, M., Kodrasov, M. P., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.007 · Cited by 589
The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network
Song, M. S., Salmena, L., Carracedo, A., Egia, A., Lo-Coco, F., Teruya-Feldstein, J., & Pandolfi, P. P. (2008) · Nature · doi:10.1038/nature07290 · Cited by 548
A novel ubiquitin‐specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein
Everett, R. D., Meredith, M., Orr, A., Cross, A., Kathoria, M., & Parkinson, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.7.1519 · Cited by 491

Show all 114 references

Sorted by citations

Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
Ubiquitin–proteasome system (UPS) as a target for anticancer treatment
Park, J., Cho, J., & Song, E. J. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01281-8 · Cited by 430
Mitochondrial quality control in cardiac microvascular ischemia-reperfusion injury: New insights into the mechanisms and therapeutic potentials
Wang, J., Toan, S., & Zhou, H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104771 · Cited by 187
Advances in Discovering Deubiquitinating Enzyme (DUB) Inhibitors
Schauer, N. J., Magin, R. S., Liu, X., Doherty, L. M., & Buhrlage, S. J. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01138 · Cited by 191
Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?
Qi, S., Cheng, G., Cheng, X., Xu, Z., Xu, B., Zhang, W., & Qin, J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00233 · Cited by 167
USP7 inhibits Wnt/β-catenin signaling through promoting stabilization of Axin
Ji, L., Lu, B., Zamponi, R., Charlat, O., Aversa, R. J., Yang, Z., Sigoillot, F. D., Zhu, X., Hu, T., Reece-Hoyes, J. S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12143-3 · Cited by 135
Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application
Gao, H., Yin, J., Ji, C., Yu, X., Xue, J., Guan, X., Zhang, S., Liu, X., & Xing, F. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02805-y · Cited by 135
Neuroinflammation inhibition by small-molecule targeting USP7 noncatalytic domain for neurodegenerative disease therapy
Zhang, X.-W., Feng, N., Liu, Y.-C., Guo, Q., Wang, J., Bai, Y.-Z., Ye, X., Yang, Z., Yang, H., Liu, Y., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo0789 · Cited by 122
Merkel Cell Polyomavirus and Merkel Cell Carcinoma
Pietropaolo, V., Prezioso, C., & Moens, U. L. (2020) · Cancers · doi:10.3390/cancers12071774 · Cited by 120
USP7 Is a Master Regulator of Genome Stability
Valles, G. J., Bezsonova, I., Woodgate, R., & Ashton, N. W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00717 · Cited by 114
“Although outside the scope of this review, USP7 likely also contributes to carcinogenesis by regulating a number of tumor suppressors and oncogenes with roles outside of direct genome stability maintenance (Bhattacharya et al., 2018).”
BackgroundInfluential
m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway
Lin, K., Zhou, E., Shi, T., Zhang, S., Zhang, J., Zheng, Z., Pan, Y., Gao, W., & Yu, Y. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02792-0 · Cited by 91
Targeting the Ubiquitin–Proteasome System and Recent Advances in Cancer Therapy
Spano, D., & Catara, G. (2023) · Cells · doi:10.3390/cells13010029 · Cited by 86
Molecular Mechanisms of DUBs Regulation in Signaling and Disease
Li, Y., & Reverter, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22030986 · Cited by 92
Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor Activity
Leger, P. R., Hu, D. X., Biannic, B., Bui, M., Han, X., Karbarz, E., Maung, J., Okano, A., Osipov, M., Shibuya, G. M., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00245 · Cited by 78
USP7 deubiquitinates and stabilizes EZH2 in prostate cancer cells
Lee, J. E., Park, C. M., & Kim, J. H. (2020) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2019-0338 · Cited by 72
Inhibition of USP7 induces p53-independent tumor growth suppression in triple-negative breast cancers by destabilizing FOXM1
Yi, J., Li, H., Chu, B., Kon, N., Hu, X., Hu, J., Xiong, Y., Kanıskan, H. Ü., Jin, J. J., & Gu, W. J. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01180-7 · Cited by 70
USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia
Shan, H., Li, X., Xiao, X., Dai, Y., Huang, J., Song, J., Liu, M., Yang, L., Lei, H., Tong, Y., et al. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0028-3 · Cited by 66
Highlights in USP7 inhibitors for cancer treatment
Oliveira, R. I., Guedes, R. A., & Salvador, J. A. R. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.1005727 · Cited by 64
PTEN inhibition attenuates endothelial cell apoptosis in coronary heart disease via modulating the AMPK–CREB–Mfn2‐mitophagy signaling pathway
Li, P., Wang, J., Zhao, X., Ru, J., Tian, T., An, Y., Tang, L., & Bai, Y. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29366 · Cited by 58
Flap endonuclease 1 Facilitated Hepatocellular Carcinoma Progression by Enhancing USP7/MDM2-mediated P53 Inactivation
Bian, S., Ni, W., Zhu, M., Zhang, X., Qiang, Y., Zhang, J., Ni, Z., Shen, Y., Qiu, S., Song, Q., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.68179 · Cited by 57
Nuclear deubiquitination in the spotlight: the multifaceted nature of USP7 biology in disease
Rawat, R., Starczynowski, D. T., & Ntziachristos, P. (2019) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2019.02.008 · Cited by 54
EZH2 Regulates Protein Stability via Recruiting USP7 to Mediate Neuronal Gene Expression in Cancer Cells
Lei, A., Chen, L., Zhang, M., Yang, X., Xu, L., Cao, N., Zhang, Z., & Cao, Y. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00422 · Cited by 54
Recent advances on the intervention sites targeting USP7-MDM2-p53 in cancer therapy
Harakandi, C., Nininahazwe, L., Xu, H., Liu, B., He, C., Zheng, Y., & Zhang, H. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105273 · Cited by 53
The deubiquitinase USP7 uses a distinct ubiquitin-like domain to deubiquitinate NF-ĸB subunits
Mitxitorena, I., Somma, D., Mitchell, J. P., Lepistö, M., Tyrchan, C., Smith, E., Kiely, P. A., Walden, H., Keeshan, K., & Carmody, R. J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014113 · Cited by 51
USP7 as an emerging therapeutic target: A key regulator of protein homeostasis
Guo, N.-J., Wang, B., Zhang, Y., Kang, H., Nie, H., Feng, M.-K., Zhang, X.-Y., Zhao, L., Wang, N., Liu, H., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.130309 · Cited by 52
CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool
Baghini, S. S., Gardanova, Z. R., Abadi, S. A. H., Zaman, B. A., İlhan, A., Shomali, N., Adili, A., Moghaddar, R., & Yaseri, A. F. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00336-6 · Cited by 46
Pharmacological inhibition of USP7 promotes antitumor immunity and contributes to colon cancer therapy
Fu, C., Zhu, X., Xu, P., & Li, Y. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s182806 · Cited by 45
Ubiquitin-specific protease 7 is a drug-able target that promotes hepatocellular carcinoma and chemoresistance
Zhang, W., Zhang, J., Xu, C., Zhang, S., Bian, S., Jiang, F., Ni, W., Qu, L., Lu, C., Ni, R., et al. (2020) · Cancer Cell International · doi:10.1186/s12935-020-1109-2 · Cited by 43
Targeting the USP7/RRM2 axis drives senescence and sensitizes melanoma cells to HDAC/LSD1 inhibitors
Granieri, L., Marocchi, F., Melixetian, M. B., Mohammadi, N., Nicoli, P., Cuomo, A., Bonaldi, T., Confalonieri, S., Pisati, F., Giardina, G., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111396 · Cited by 43
USP7 Inhibitors in Cancer Immunotherapy: Current Status and Perspective
Korenev, G., Yakukhnov, S., Druk, A., Golovina, A., Chasov, V. V., Mirgayazova, R., Ivanov, R. A., & Bulatov, E. (2022) · Cancers · doi:10.3390/cancers14225539 · Cited by 44
Inhibition of ubiquitin-specific protease 7 sensitizes acute myeloid leukemia to chemotherapy
Cartel, M., Mouchel, P., Gotanègre, M., David, L., Bertoli, S., Mas, V. M., Besson, A., Sarry, J., Manenti, S., & Didier, C. (2020) · Leukemia · doi:10.1038/s41375-020-0878-x · Cited by 43
Novel, Selective Inhibitors of USP7 Uncover Multiple Mechanisms of Antitumor Activity In Vitro and In Vivo
Ohol, Y. M., Sun, M. T., Cutler, G., Leger, P. R., Hu, D. X., Biannic, B., Rana, P., Cho, C., Jacobson, S., Wong, S., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0184 · Cited by 41
USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma
Saha, G., Sarkar, S., Mohanta, P. S., Kumar, K., Chakrabarti, S., Basu, M., & Ghosh, M. K. (2022) · Oncogene · doi:10.1038/s41388-022-02486-5 · Cited by 41
Self-citation
USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1
Lin, Y., Lin, J., Liu, Y.-E., Chen, Y.-C., Liu, S.-T., Hsu, K., Chen, D., & Wu, H.-T. (2022) · Cells · doi:10.3390/cells11203294 · Cited by 40
Reversal of viral and epigenetic HLA class I repression in Merkel cell carcinoma
Lee, P. C., Klaeger, S., Le, P. M., Korthauer, K. D., Cheng, J., Ananthapadmanabhan, V., Frost, T. C., Stevens, J. D., Wong, A. Y. L., Iorgulescu, J. B., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci151666 · Cited by 38
USP7-SOX9-miR-96-5p-NLRP3 Network Regulates Myocardial Injury and Cardiomyocyte Pyroptosis in Sepsis
Gong, X., Li, Y., He, Y., & Zhou, F. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.078 · Cited by 38
Renal tubular cell death and inflammation response are regulated by the MAPK-ERK-CREB signaling pathway under hypoxia-reoxygenation injury
Dong, Q. R., Jie, Y., Ma, J., Li, C., Xin, T., & Yang, D. (2019) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2019.1698050 · Cited by 36
Unstructured Biology of Proteins from Ubiquitin-Proteasome System: Roles in Cancer and Neurodegenerative Diseases
Gadhave, K., Kumar, P., Kapuganti, S. K., Uversky, V. N., & Giri, R. (2020) · Biomolecules · doi:10.3390/biom10050796 · Cited by 36
IU1 suppresses proliferation of cervical cancer cells through MDM2 degradation
Liu, X., Wang, J., Yuan, X., Yang, S., Xu, X., Li, K., He, Y., Wei, L., Zhang, J., & Tian, Y. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.47999 · Cited by 37
The USP7-TRIM27 axis mediates non-canonical PRC1.1 function and is a druggable target in leukemia
Maat, H., Atsma, T. J., Hogeling, S. M., López, A. R., Jaques, J., Olthuis, M., de Vries, M. P., Gravesteijn, C., Brouwers-Vos, A. Z., van der Meer, N. K., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102435 · Cited by 39
The tumour-promoting role of protein homeostasis: Implications for cancer immunotherapy
Liang, R., Tan, H., Jin, H., Wang, J., Tang, Z., & Lu, X. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216354 · Cited by 34
Role of deubiquitinases in DNA damage response
Le, J. P., Perez, E., Nemzow, L., & Gong, F. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.02.011 · Cited by 34
Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy
Pluciennik, A., Liu, Y., Molotsky, E., Marsh, G. B., Ranxhi, B., Arnold, F. J., St.-Cyr, S., Davidson, B. L., Pourshafie, N., Lieberman, A. P., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134565 · Cited by 30
USP7 inhibits TIMP2 by up-regulating the expression of EZH2 to activate the NF-κB/PD-L1 axis to promote the development of cervical cancer
Li, N., Geng, F., Liang, S., & Qin, X. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110351 · Cited by 29
USP7 Inhibits Osteoclastogenesis via Dual Effects of Attenuating TRAF6/TAK1 Axis and Stimulating STING Signaling
Xie, Z., Wu, Y., Shen, Y., Guo, J., Yuan, P., Ma, Q., Wang, S., Jie, Z., Zhou, H., Fan, S., et al. (2023) · Aging and Disease · doi:10.14336/ad.2023.0325-1 · Cited by 28
Strategies that regulate LSD1 for novel therapeutics
Li, M., Dai, M., Cheng, B., Li, S., Guo, E., Fu, J., Ma, T., & Yu, B. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.01.005 · Cited by 27
Deubiquitinases: Pro-oncogenic Activity and Therapeutic Targeting in Blood Malignancies
Gutierrez-Diaz, B. T., Gu, W. J., & Ntziachristos, P. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.02.004 · Cited by 26
p53: from understanding its structure to advances in therapeutic targeting
Wang, W., Liu, X., Liu, H., Abolhassani, H., Yan, H., Zhang, H., & Wang, X. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02549-5 · Cited by 29
DUBs Activating the Hedgehog Signaling Pathway: A Promising Therapeutic Target in Cancer
Bufalieri, F., Severini, L. L., Caimano, M., Infante, P., & Marcotullio, L. D. (2020) · Cancers · doi:10.3390/cancers12061518 · Cited by 25
Assay Systems for Profiling Deubiquitinating Activity
Cho, J., Park, J., Kim, E. E., & Song, E. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165638 · Cited by 24
Mitochondria, mitophagy, and the role of deubiquitinases as novel therapeutic targets in liver pathology
Aryapour, E., & Kietzmann, T. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30312 · Cited by 24
USP7 substrates identified by proteomics analysis reveal the specificity of USP7Preprint
Nie, L., Wang, C., Liu, X., Teng, H., Li, S., Huang, M., Feng, X., Pei, G., Hang, Q., Zhao, Z., et al. (2022) · Genes & Development · doi:10.1101/gad.349848.122 · Cited by 24
USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities
Liu, C., Sun, L., Tan, Y., Wang, Q. T., Luo, T., Li, C., Yao, N., Xie, Y., Yi, X., Zhu, Y., et al. (2023) · Science Advances · doi:10.1126/sciadv.ade3888 · Cited by 23
USP7 imparts partial EMT state in colorectal cancer by stabilizing the RNA helicase DDX3X and augmenting Wnt/β-catenin signaling
Basu, B., Karmakar, S., Basu, M., & Ghosh, M. K. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119446 · Cited by 24
Self-citation
Ubiquitin-Specific Protease 7 (USP7) as a Promising Therapeutic Target for Drug Discovery: From Mechanisms to Therapies
Song, Y., Ren, X., Xiong, J., Wang, W., Zhao, Q., Chang, J., & Yu, B. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00102 · Cited by 22
Signaling Activation and Modulation in Extrafollicular B Cell Responses
Staniek, J., & Rizzi, M. (2025) · Immunological Reviews · doi:10.1111/imr.70004 · Cited by 22
The ubiquitin-proteasome system in the regulation of tumor dormancy and recurrence
Alhasan, B. A., Morozov, A. V., Guzhova, I. V., & Margulis, B. A. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189119 · Cited by 20
E3 ligases and DUBs target ferroptosis: A potential therapeutic strategy for neurodegenerative diseases
Lu, L., Jifu, C., Xia, J., & Wang, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116753 · Cited by 26
USP7 stabilizes EZH2 and enhances cancer malignant progression.
Zheng, N., Chu, M., Lin, M., He, Y., & Wang, Z. P. (2020) · PubMed · Cited by 20
USP7 deubiquitinates and stabilizes SIRT1.
Song, N., Cao, C., Tian, S., Long, M., & Liu, L. (2020) · The Anatomical Record · doi:10.1002/ar.24252 · Cited by 19
Ubiquitination and deubiquitination in the regulation of epithelial-mesenchymal transition in cancer: Shifting gears at the molecular level
Basu, B., & Ghosh, M. K. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119261 · Cited by 20
Self-citation
Role of the DUB enzyme USP7 in dendritic arborization, neuronal migration, and autistic-like behaviors in mice
Qiao, H., Tian, Y., Huo, Y., & Man, H. (2022) · iScience · doi:10.1016/j.isci.2022.104595 · Cited by 19
Programmed Death Ligand 1 Regulatory Crosstalk with Ubiquitination and Deubiquitination: Implications in Cancer Immunotherapy
Kim, S.-B., Hwang, S., Cha, J.-Y., & Lee, H.-J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052939 · Cited by 19
Cerebral ischemia‐reperfusion is modulated by macrophage‐stimulating 1 through the MAPK‐ERK signaling pathway
Zhou, D., Zhang, M., Min, L., Jiang, K., & Jiang, Y. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29603 · Cited by 18
A feedforward circuit shaped by ECT2 and USP7 contributes to breast carcinogenesis
Zhang, Q., Cao, C., Gong, W., Bao, K., Wang, Q., Wang, Y., Bi, L., Ma, S., Zhao, J., Liu, L., et al. (2020) · Theranostics · doi:10.7150/thno.46878 · Cited by 18
The key vulnerabilities and therapeutic opportunities in the USP7-p53/MDM2 axis in cancer
Saha, G., & Ghosh, M. K. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2025.119908 · Cited by 18
Self-citation
Ubiquitin Ligases in Control: Regulating NLRP3 Inflammasome Activation
Beesetti, S. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl25970 · Cited by 18
LATS2 promotes cardiomyocyte H9C2 cells apoptosis via the Prx3-Mfn2-mitophagy pathways
Tian, Y., Lv, W., Lu, C., Zhao, X., Zhang, C., & Song, H. (2019) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2019.1701031 · Cited by 17
Deubiquitinases: Modulators of Different Types of Regulated Cell Death
Lee, C.-S., Kim, S., Hwang, G., & Song, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094352 · Cited by 17
Genetically encoded fluorescent unnatural amino acids and FRET probes for detecting deubiquitinase activities
Li, M., Wang, F., Yan, L., Lu, M., Zhang, Y., & Peng, T. (2022) · Chemical Communications · doi:10.1039/d2cc03623a · Cited by 17
Redox‐Induced Stabilization of AMBRA1 by USP7 Promotes Intestinal Oxidative Stress and Colitis Through Antagonizing DUB3‐Mediated NRF2 Deubiquitination
Xu, W., Hua, Z., Wang, Y., Tang, W., Ge, W., Chen, Y., Wang, Z., Gu, Y., Liu, C., & Du, P. (2025) · Advanced Science · doi:10.1002/advs.202411320 · Cited by 16
Novel modulators of p53-signaling encoded by unknown genes of emerging viruses
Alzhanova, D. V., Corcoran, K., Bailey, A., Long, K. M., Taft-Benz, S., Graham, R. L., Broussard, G. S., Heise, M. T., Neumann, G., Halfmann, P., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009033 · Cited by 17
Deubiquitylation and stabilization of ARMC5 by ubiquitin‐specific processing protease 7 (USP7) are critical for RCC proliferation
Yan, G., Liu, N., Tian, J., Fu, Y., Wei, W., Zou, J., Li, S., Wang, Q., Li, K., & Wang, J. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16306 · Cited by 16
USP7 promotes PINK1/Parkin-dependent mitophagy to ameliorate cerebral ischemia–reperfusion injury by deubiquitinating and stabilizing SIRT1
Hou, D., Hu, Y., Tian, Y., Yu, D., & Yang, G. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149638 · Cited by 15
AML with complex karyotype: extreme genomic complexity revealed by combined long-read sequencing and Hi-C technology
Klever, M.-K., Sträng, E., Hetzel, S., Jungnitsch, J., Dolnik, A., Schöpflin, R., Schrezenmeier, J., Schick, F., Blau, O., Westermann, J., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023010887 · Cited by 15
Role of melatonin in mitigation of insulin resistance and ensuing diabetic cardiomyopathy
Nath, A., Ghosh, S., & Bandyopadhyay, D. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122993 · Cited by 15
MKP1 reduces neuroinflammation via inhibiting endoplasmic reticulum stress and mitochondrial dysfunction
Huang, D., & Jiang, Y. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29308 · Cited by 15
PE_PGRS38 Interaction With HAUSP Downregulates Antimycobacterial Host Defense via TRAF6
Kim, J., Kim, H. K., Cho, E., Mun, S., Jang, S., Jang, J., & Yang, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.862628 · Cited by 15
Melatonin receptor protects cardiomyocyte against oxidative stress-induced apoptosis through the MAPK-ERK signaling pathway
Li, P., Hu, F., Cao, X., Luo, L., & Tu, Q. (2020) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2020.1719151 · Cited by 14
WD repeat-containing protein 1 maintains β-Catenin activity to promote pancreatic cancer aggressiveness
Li, H., Liu, X., Jiang, S., Zhou, X., Yao, L., Yang, D., Jiang, Y., Gu, J., Mao, Y., Li, J., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0929-0 · Cited by 14
Prognostic role of USP7 expression in cancer patients: A systematic review and meta-analysis
Kisaï, K. K., & Koji, S. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153621 · Cited by 15
USP7 Inhibition Suppresses Neuroblastoma Growth via Induction of p53-Mediated Apoptosis and EZH2 and N-Myc Downregulation
Clorennec, C. L., Lee, K. S., Huo, Y., & Zage, P. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813780 · Cited by 16
Gene analysis of major signaling pathways regulated by gonadotropins in human ovarian granulosa tumor cells (KGN)†
Tremblay, P. G., & Sirard, M. (2020) · Biology of Reproduction · doi:10.1093/biolre/ioaa079 · Cited by 14
Deubiquitinating Enzyme USP7 Is Required for Self-Renewal and Multipotency of Human Bone Marrow-Derived Mesenchymal Stromal Cells
Kim, Y. J., Park, K. H., Lee, K., Chun, Y., & Lee, J. W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158674 · Cited by 14
BK Channel Deficiency in Osteoblasts Reduces Bone Formation via the Wnt/β-Catenin Pathway
Jiang, L., Yang, Q., Jianjun, G., Yang, J., He, J., Xin, H., & Zhang, X. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.0004 · Cited by 12
Design, synthesis and biological evaluation of 2-aminopyridine derivatives as USP7 inhibitors
Xu, X., Wang, M., Xu, H., Liu, N., Chen, K., Luo, C., Chen, S., & Chen, H. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106128 · Cited by 12
Liraglutide reduces hyperglycemia-induced cardiomyocyte death through activating glucagon-like peptide 1 receptor and targeting AMPK pathway
Ma, G., Liu, Y., Wang, Y., Wen, Z., Li, X., Zhai, H., Li, M., & Luo, J. (2020) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2020.1719517 · Cited by 12
The roles of ribosomal proteins in nasopharyngeal cancer: culprits, sentinels or both
Sim, E. U., Lee, C. W., & Narayanan, K. (2021) · Biomarker Research · doi:10.1186/s40364-021-00311-x · Cited by 12
The prognostic value of USP7 and p53 in advanced hypopharyngeal carcinoma
Sun, J., Lin, L., Zhang, J., Hu, C., & Wang, J. (2021) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2020.151695 · Cited by 11
EVC-EVC2 complex stability and ciliary targeting are regulated by modification with ubiquitin and SUMO
Barbeito, P., Martin-Morales, R., Palencia‐Campos, A., Cerrolaza, J., Rivas-Santos, C., Gallego-Colastra, L., Caparros-Martin, J. A., Martin-Bravo, C., Martín-Hurtado, A., Sánchez-Bellver, L., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1190258 · Cited by 10
USP7 reduces the level of nuclear DICER , impairing DNA damage response and promoting cancer progression
Liu, X., Lu, R., Yang, Q., He, J., Huang, C., Cao, Y., Zhou, Z., Huang, J., Li, L., Chen, R., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13543 · Cited by 10
Ubiquitin‐specific peptidase 7 (USP7) and USP10 mediate deubiquitination of human NHE3 regulating its expression and activity
Han, Y., & Yun, C. C. (2020) · The FASEB Journal · doi:10.1096/fj.202001875r · Cited by 10
IKZF1 selectively enhances homologous recombination repair by interacting with CtIP and USP7 in multiple myeloma
Liu, M., Zhang, Y., Wu, Y., Jin, J., Cao, Y., Fang, Z., Geng, L., Yang, L., Yu, M., Bu, Z., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.70960 · Cited by 10
In vivo CRISPR screens identify Mga as an immunotherapy target in triple-negative breast cancer
Xu, F., Yang, C. Q., Huang, Y., Su, D., Wang, C., Wilson, L., Yin, L., Tang, M., Li, S., Chen, Z., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2406325121 · Cited by 9
Involvement of USP7 in aggravating Kawasaki disease by promoting TGFβ2 signaling mediated endothelial-mesenchymal transition and coronary artery remodeling
Qian, G., Wang, Y., Yao, H., Zhang, Z.-M., Wang, W., Xu, L., Li, W., Huang, L., Li, X., Gao, Y., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113823 · Cited by 9
Ubiquitin-specific proteases as therapeutic targets in paediatric primary bone tumours?
Mullard, M., Lavaud, M., Regnier, L., Tesfaye, R. A., Ory, B., Rédiní, F., & Verrecchia, F. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114797 · Cited by 9
NURR1 inhibition reduces hypoxia-mediated cardiomyocyte necrosis via blocking Mst1-JNK-mPTP pathway
Ma, G., & Liu, Y. (2019) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2019.1690514 · Cited by 9
Yes-associated protein reduces neuroinflammation through upregulation of Sirt3 and inhibition of JNK signaling pathway
Yang, Y., Gong, Z., & Wang, Z. (2019) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2019.1705339 · Cited by 9
Comprehensive analysis of the relationship between ubiquitin-specific protease 21 (USP21) and prognosis, tumor microenvironment infiltration, and therapy response in colorectal cancer
Nie, H., Yu, Y., Wang, F., Huang, X., Wang, H., Wang, J., Tao, M., Ning, Y., Zhou, J., Zhao, Q., et al. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03731-4 · Cited by 8
USP7 regulates growth and maintains the stemness of p53-mutant colorectal cancer cells via stabilizing of mutant p53
Li, X., Pan, J., & Zheng, P. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1427663 · Cited by 8

Authors: Bhattacharya, S., Chakraborty, D., Basu, M., & Ghosh, M. K.
Affiliations: Indian Institute of Chemical Biology (IN)
Surendranath College (IN)
Corresponding author: Ghosh, Mrinal K
ORCID: Bhattacharya, Seemana
Basu, Malini
Ghosh, Mrinal K
Venue: Signal Transduction and Targeted Therapy
Publisher: Springer Science and Business Media LLC
Published: 2018-06-29
Volume: 3
Issue: 1
Pages: 17-17
ISSN: 2059-3635 (ISSN-L)
DOI: 10.1038/s41392-018-0012-y
PMC: PMC6023882
OpenAlex: W2809511392
Cited by: 162
References: 114
Citations by year: 2026: 8 · 2025: 27 · 2024: 16 · 2023: 23 · 2022: 29 · 2021: 15 · 2020: 26 · 2019: 16 · 2018: 1
FWCI: 5.34
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0 (tdm)
creativecommons.org/licenses/by/4.0 (vor)
Locations: Signal Transduction and Targeted Therapy (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders: Department of Biotechnology, Ministry of Science and Technology, India
Department of Science and Technology, Ministry of Science and Technology, India (SR/NM/NS-1058/2015)
Council of Scientific and Industrial Research, India
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
Keywords: USP7, deubiquitinase, host-virus interaction, herpesvirus, carcinogenesis, tumor suppression, DNA damage and repair, epigenetic regulation, gene expression regulation, immune function, metabolic disorders, neurological disorders, therapeutic target

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases.

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks